ALTERATION OF BLOOD BRAIN BARRIER (BBB) PERMEABILITY BY TUMOR TREATING FIELDS (TTFIELDS) IN VIVO

被引：1
|
作者：
Kessler, A. F. [1 ]
Salvador, E. [1 ]
Domroese, D. [1 ]
Burek, M. [2 ]
Brami, C. Tempel [3 ]
Sela, T. Voloshin [3 ]
Giladi, M. [3 ]
Ernestus, R. [1 ]
Loehr, M. [1 ]
Foerster, C. [2 ]
Hagemann, C. [1 ]
机构：
[1] Univ Wurzburg, Dept Neurosurg, Tumorbiol Lab, Wurzburg, Germany
[2] Univ Wurzburg, Dept Anesthesia & Crit Care, Div Mol Med, Wurzburg, Germany
[3] Novocure, Haifa, Israel
来源：
NEURO-ONCOLOGY | 2019年 / 21卷
关键词：
D O I：
10.1093/neuonc/noz126.174
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P11.28
引用
收藏
页码：49 / 49
页数：1
相关论文
共 50 条
  • [31] Tumor Treating Fields (TTFields) Induce Cell Junction Alterations in a Human 3D In Vitro Model of the Blood-Brain Barrier
    Salvador, Ellaine
    Koeppl, Theresa
    Hoermann, Julia
    Schoenhaerl, Sebastian
    Bugaeva, Polina
    Kessler, Almuth F.
    Burek, Malgorzata
    Ernestus, Ralf-Ingo
    Loehr, Mario
    Hagemann, Carsten
    PHARMACEUTICS, 2023, 15 (01)
  • [32] PERMEABILITY ALTERATION OF BLOOD-BRAIN-BARRIER BY ALCOHOLS
    GULATI, A
    NATH, C
    DHAWAN, KN
    SHANKER, K
    BHARGAVA, KP
    INDIAN JOURNAL OF MEDICAL RESEARCH, 1981, 73 (MAY) : 793 - 795
  • [33] HYPERTHERMIA INCREASES BLOOD-BRAIN-BARRIER (BBB) PERMEABILITY IN THE RAT
    GUSTAFSON, AN
    ELIZONDO, RS
    FEDERATION PROCEEDINGS, 1987, 46 (03) : 683 - 683
  • [34] THE ALTERATION IN PERMEABILITY OF BLOOD-BRAIN-BARRIER FOR HYDROXYTHIAMINE
    OSTROVSKY, YM
    ZIMATKINA, TI
    OPARIN, DA
    VOPROSY MEDITSINSKOI KHIMII, 1985, 31 (05): : 119 - 121
  • [35] INCREASING CANCER CELL MEMBRANE PERMEABILITY THROUGH APPLICATION OF TUMOR TREATING FIELDS (TTFIELDS)
    Voloshin, Tali
    Koltun, Bella
    Koren, Lilach
    Porat, Yaara
    Volodin, Alexandra
    Kaynan, Noa
    Klein-Goldberg, Anat
    Paz, Rom
    Brant, Boris
    Zemer-Tov, Efrat
    Haber, Adi
    Giladi, Moshe
    Weinberg, Uri
    Palti, Yoram
    NEURO-ONCOLOGY, 2021, 23 : 180 - 180
  • [36] Tumor Treating Fields (TTFields) Concomitant with Sorafenib Inhibit Hepatocellular Carcinoma In Vitro and In Vivo
    Davidi, Shiri
    Jacobovitch, Sara
    Shteingauz, Anna
    Martinez-Conde, Antonia
    Braten, Ori
    Tempel-Brami, Catherine
    Zeevi, Einav
    Frechtel-Gerzi, Roni
    Ene, Hila
    Dor-On, Eyal
    Voloshin, Tali
    Tzchori, Itai
    Haber, Adi
    Giladi, Moshe
    Kinzel, Adrian
    Weinberg, Uri
    Palti, Yoram
    CANCERS, 2022, 14 (12)
  • [37] In vitro and in vivo evidence for the safety and efficacy of Tumor Treating Fields (TTFields) in combination with sorafenib
    Davidi, Shiri
    Tempel-Brami, Catherine
    Munster, Mijal
    Shteingauz, Anna
    Zeevi, Einav
    Schneiderman, Rosa
    Voloshin, Tali
    Giladi, Moshe
    Kinzel, Adrian
    Weinberg, Uri
    Palti, Yoram
    CANCER RESEARCH, 2020, 80 (16)
  • [38] THE INOVIVO SYSTEM: A NOVEL PRECLINICAL TOOL FOR IN VIVO DELIVERY OF TUMOR TREATING FIELDS (TTFIELDS)
    Davidi, Shiri
    Blat, Roni
    Shteingauz, Anna
    Porat, Yaara
    Giladi, Moshe
    Weinberg, Uri
    Palti, Yoram
    NEURO-ONCOLOGY, 2020, 22 : 104 - 104
  • [39] Tumor treating fields (TTFields) in combination with sorafenib inhibit hepatocellular carcinoma in vitro and in vivo
    Potter, Wyatt
    Davidi, Shiri
    Jacobovitch, Sara
    Shteingauz, Anna
    Tempel-Brami, Catherine
    Zeevi, Einav
    Dor-On, Eyal
    Schneiderman, Rosa S.
    Voloshin, Tali
    Tzchori, Itai
    Haber, Adi
    Giladi, Moshe
    Kinzel, Adrian
    Weinberg, Uri
    Palti, Yoram
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [40] Examination of blood–brain barrier (BBB) integrity in a mouse brain tumor model
    Ngoc H. On
    Ryan Mitchell
    Sanjot D. Savant
    Corbin. J. Bachmeier
    Grant M. Hatch
    Donald W. Miller
    Journal of Neuro-Oncology, 2013, 111 : 133 - 143
12345